Mirum Pharmaceuticals, Inc. (MIRM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.97B |
| Enterprise Value | 3.99B |
| P/E Ratio | -7.92 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 9.5 |
| Price/Book Ratio | 26.15 |
| Enterprise/Revenue | 9.5 |
| Enterprise/EBITDA | -7.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.4 |
| Operating Margin | -0.12 |
| Return On Assets | -0.9 |
| Return On Equity | -2.89 |
| Revenue | 521.31M |
| Revenue/Share | 9.68 |
| Gross Profit | 420.73M |
| EBITDA | 17.21M |
| Net Income | -23.36M |
| Diluted EPS | -0.47 |
| Total Cash | 386.26M |
| Total Cash/Share | 6.56 |
| Total Debt | 323.78M |
| Total Debt/Equity | 1.34 |
| Current Ratio | 2.09 |
| Book Value Per Share | 4.12 |
| 52-Week Change | 114.34 |
| 52-Week High | 114.99 |
| 52-Week Low | 47.89 |
| Moving Average 50 Days | 98.63 |
| Moving Average 200 Days | 86.16 |
| Average Volume | 954,177 |
| Shares Outstanding | 50.2M |
| % Held by Institutions | 135.96 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |